Old Web
English
Sign In
Acemap
>
authorDetail
>
Kevin Zarrabi
Kevin Zarrabi
Fox Chase Cancer Center
Internal medicine
Medicine
Oncology
Immunotherapy
Clear cell
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-world outcomes in patients with metastatic clear cell renal cell carcinoma receiving front-line axitinib plus pembrolizumab versus ipilimumab plus nivolumab.
2021
Journal of Clinical Oncology
Kevin Zarrabi
Elizabeth Handorf
Benjamin Miron
Matthew Zibelman
Fern Anari
Pooja Ghatalia
Elizabeth R. Plimack
Daniel M. Geynisman
Show All
Source
Cite
Save
Citations (0)
Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who receive second-line immunotherapy.
2021
Journal of Clinical Oncology
Benjamin Miron
Elizabeth Handorf
Kevin Zarrabi
Matthew Zibelman
Pooja Ghatalia
Fern Anari
Elizabeth R. Plimack
Daniel M. Geynisman
Show All
Source
Cite
Save
Citations (0)
Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities
2021
Cancers
Kevin Zarrabi
Emily Walzer
Matthew Zibelman
Show All
Source
Cite
Save
Citations (0)
Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer’s syndrome
2019
Urology case reports
Kevin Zarrabi
Selma Masic
Christopher Schaefer
Michael J. Bartel
Alexander Kutikov
Matthew Zibelman
Show All
Source
Cite
Save
Citations (2)
1